HIF1A and neoplasm: Moreover, the most recent evidence has indicated that tumor-released succinate can activate succinate receptor 1 (SUCNR1) signaling to polarize TAMs toward tumor-supporting phenotypes through a SUCNR1-activated PI3K/HIF-1α axis (85).